 another biotech company Nova vac says it started a human study of an experimental vaccine the first patient out of about a hundred and thirty participants received a dose on Monday in Australia the company says it expects initial results on immune responsiveness by July after that Nova VAX would begin a second round of testing that would include the u.s. 